Recruiting
Phase 3

Tildrakizumab

Sponsor:

Sun Pharmaceutical Industries Limited

Code:

NCT04991116

Conditions

Psoriatic Arthritis

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

TILD sub-cutaneous (SC) injection

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-08-18. This information was provided to ClinicalTrials.gov by Sun Pharmaceutical Industries Limited on 2025-03-04.